MAPT and Alzheimer disease: Using immunofluorescence and peroxidase-based immunostaining, we found substantial pS396-tau depositions across all retinal layers in MCI and AD patients compared to NC controls (Fig. 5a–c; arrowheads indicate intraneuronal p-tau structures).